# MAGEB4

## Overview
MAGEB4 is a gene that encodes the protein MAGE family member B4, which is part of the melanoma antigen family. This protein is primarily expressed in germ cells, particularly in the testis, and is involved in germ cell differentiation. MAGEB4 is categorized as a cancer/testis antigen (CTA), a group of proteins typically expressed in human germ cells and various tumors, suggesting a potential role in tumorigenesis (Vandenbrouck2020The). The protein consists of 346 amino acids and features a MAGE homology domain, which is a conserved structural motif among MAGE family proteins (Barker2002The). MAGEB4 is capable of forming homodimers and interacting with other MAGE proteins, such as MAGEA3, indicating its involvement in protein-protein interactions (Okutman2017A). While its precise physiological role in healthy human cells remains largely unexplored, mutations in the MAGEB4 gene have been linked to male infertility and its expression has been implicated in various cancers, including hepatocellular carcinoma (Li2020A; Okutman2017A).

## Structure
The MAGEB4 gene encodes a protein that is part of the melanoma antigen family, specifically expressed in germ cells. The protein consists of 346 amino acids and includes a MAGE homology domain (MHD) starting at residue 109, which is a conserved feature across many MAGE family proteins (Barker2002The). This domain is approximately 165-171 amino acids long and contains potential α-helical and β-sheet structures, although the exact function of these structures remains unclear (Barker2002The).

A notable structural feature of MAGEB4 is an additional 37 residues at the C-terminal end compared to MAGEA3, another member of the MAGE family. Secondary structure predictions suggest the presence of α-helix and β-sheet regions in this C-terminal extension, which likely do not disrupt the protein's ability to form homodimers (Okutman2017A). The protein is capable of forming homodimers and can interact with other MAGE proteins, such as MAGEA3, indicating a potential role in protein-protein interactions (Okutman2017A).

The MAGEB4 protein is primarily localized at the cell membrane, as indicated by immunofluorescence labeling studies, and its expression is predominantly found in the testis, particularly in differentiating germ cells (Okutman2017A).

## Function
MAGEB4 (Melanoma Antigen Family B4) is a member of the MAGE gene family, which is primarily expressed in the testis and plays a role in germ cell differentiation. It is highly expressed during the differentiation of germ cells before meiosis, suggesting a role in oocyte development (Li2021Pathogenicity). MAGEB4 is part of the cancer/testis antigens (CTA) family, which are typically expressed in human germ cells and various tumors, indicating a potential role in tumorigenesis (Vandenbrouck2020The).

In healthy human cells, MAGEB4 is expressed at low levels during all stages of spermatogenesis and is thought to be involved in maintaining proliferating gonocytes in a non-proliferative state (Vandenbrouck2020The). The gene is specifically expressed in germ cells, with its expression restricted to the testis, showing high levels in differentiating germ cells and minimal expression in Sertoli cells (Okutman2017A). MAGEB4's interaction with other proteins, such as MAGEA3, and its ability to form homodimers, suggest it may have a role in protein-protein interactions crucial for its function (Okutman2017A). Despite these insights, the precise physiological role of MAGEB4 in healthy human cells remains largely unexplored (Okutman2017A).

## Clinical Significance
Mutations and alterations in the MAGEB4 gene have been implicated in several clinical conditions. A study identified a no-stop mutation in the MAGEB4 gene in a consanguineous Turkish family, which is associated with rare X-linked azoospermia and oligozoospermia. This mutation replaces the stop codon with a cysteine residue, potentially adding 24 amino acids to the C-terminus of the MAGEB4 protein. The mutation was found to segregate with the infertility phenotype in the family, suggesting it may be a cause of male infertility due to its role in spermatogenesis (Okutman2017A).

In the context of cancer, MAGEB4 is part of the melanoma antigen family, which is known for its role in various cancers. Alterations in MAGEB4 expression have been observed in hepatocellular carcinoma (HCC), where it is significantly down-regulated in tumor tissues compared to non-tumor tissues. Its expression level is correlated with clinicopathological features such as vascular invasion and AFP levels, indicating its potential as a prognostic and diagnostic marker for HCC (Li2020A). Additionally, MAGEB4 has been identified as a potential autoimmune target in autoimmune polyendocrine syndrome type 1 (APS1), where autoantibodies against it were detected in patients (Landegren2016Proteomewide).

## Interactions
MAGEB4, a member of the melanoma antigen family, is involved in protein interactions that may play a role in male infertility. The study by Okutman et al. explored the interactions of MAGEB4, particularly focusing on a no-stop mutation that results in a protein with an extended C-terminal end. Despite this extension, the mutant MAGEB4 protein was found to interact effectively with both wild-type and mutant forms of itself, as well as with MAGEA3, another member of the MAGE family. This suggests that the mutation does not disrupt the protein's ability to form homodimers or interact with other MAGE proteins (Okutman2017A).

The structural analysis indicated that MAGEB4 is highly homologous to MAGEA3, with the C-terminal extension in the mutant form not affecting the homodimeric interface. This was consistent with co-immunoprecipitation experiments, which confirmed the ability of MAGEB4 to maintain its interaction capabilities despite the mutation (Okutman2017A). These findings highlight the potential role of MAGEB4 in spermatogenesis and its involvement in the pathogenesis of azoospermia and oligozoospermia, although the precise mechanisms of these interactions remain to be fully elucidated.


## References


[1. (Li2021Pathogenicity) Sanyan Li, Xiang Shi, Jingping Li, and Xianrong Zhou. Pathogenicity of the mage family (review). Oncology Letters, October 2021. URL: http://dx.doi.org/10.3892/ol.2021.13105, doi:10.3892/ol.2021.13105. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2021.13105)

[2. (Barker2002The) Philip A. Barker and Amir Salehi. The mage proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. Journal of Neuroscience Research, 67(6):705–712, February 2002. URL: http://dx.doi.org/10.1002/jnr.10160, doi:10.1002/jnr.10160. This article has 243 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jnr.10160)

[3. (Vandenbrouck2020The) Yves Vandenbrouck, Charles Pineau, and Lydie Lane. The functionally unannotated proteome of human male tissues: a shared resource to uncover new protein functions associated with reproductive biology. Journal of Proteome Research, 19(12):4782–4794, October 2020. URL: http://dx.doi.org/10.1021/acs.jproteome.0c00516, doi:10.1021/acs.jproteome.0c00516. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jproteome.0c00516)

[4. (Landegren2016Proteomewide) Nils Landegren, Donald Sharon, Eva Freyhult, Åsa Hallgren, Daniel Eriksson, Per-Henrik Edqvist, Sophie Bensing, Jeanette Wahlberg, Lawrence M. Nelson, Jan Gustafsson, Eystein S. Husebye, Mark S. Anderson, Michael Snyder, and Olle Kämpe. Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1. Scientific Reports, February 2016. URL: http://dx.doi.org/10.1038/srep20104, doi:10.1038/srep20104. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep20104)

[5. (Li2020A) Rong Li, Jiao Gong, Cuicui Xiao, Shuguang Zhu, Zhongying Hu, Jinliang Liang, Xuejiao Li, Xijing Yan, Xijian Zhang, Danyang Li, Wei Liu, Yutian Chong, and Yusheng Jie. A comprehensive analysis of the mage family as prognostic and diagnostic markers for hepatocellular carcinoma. Genomics, 112(6):5101–5114, November 2020. URL: http://dx.doi.org/10.1016/j.ygeno.2020.09.026, doi:10.1016/j.ygeno.2020.09.026. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2020.09.026)

[6. (Okutman2017A) Ozlem Okutman, Jean Muller, Valerie Skory, Jean Marie Garnier, Angeline Gaucherot, Yoni Baert, Valérie Lamour, Munevver Serdarogullari, Meral Gultomruk, Albrecht Röpke, Sabine Kliesch, Viviana Herbepin, Isabelle Aknin, Moncef Benkhalifa, Marius Teletin, Emre Bakircioglu, Ellen Goossens, Nicolas Charlet-Berguerand, Mustafa Bahceci, Frank Tüttelmann, and STéphane Viville. A no-stop mutation in mageb4 is a possible cause of rare x-linked azoospermia and oligozoospermia in a consanguineous turkish family. Journal of Assisted Reproduction and Genetics, 34(5):683–694, April 2017. URL: http://dx.doi.org/10.1007/s10815-017-0900-z, doi:10.1007/s10815-017-0900-z. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10815-017-0900-z)